Optimizing outcomes and bridging biliary atresia into adulthood
Ronald J. Sokol, Cara L. Mack – 19 January 2005
Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol‐induced oxidative DNA damage in rodent liver
Blair U. Bradford, Hiroshi Kono, Fuyumi Isayama, Oksana Kosyk, Michael D. Wheeler, Taro E. Akiyama, Lisa Bleye, Kristopher W. Krausz, Frank J. Gonzalez, Dennis R. Koop, Ivan Rusyn – 19 January 2005 – The occurrence of malignant tumors of the upper gastrointestinal tract and liver is, based largely on epidemiological evidence, causally related to the consumption of ethanol. It is widely recognized that oxidants play a key role in alcohol‐induced liver injury; however, it is unclear how oxidants may be involved in DNA damage.
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
Eduardo Schiffer, Chantal Housset, Wulfran Cacheux, Dominique Wendum, Christèle Desbois‐Mouthon, Colette Rey, François Clergue, Raoul Poupon, Véronique Barbu, Olivier Rosmorduc – 19 January 2005 – Epidermal growth factor receptor (EGFR) binds transforming growth factor α (TGF‐α) which is mitogenic for hepatocytes. Diverse lines of evidence suggest that activation of the TGF‐α /EGFR pathway contributes to hepatocellular carcinoma (HCC) formation.
p18(INK4c) expression in hepatocellular carcinoma
Tom Luedde, Frank Tacke, Michael P. Manns, Christian Trautwein – 19 January 2005
Reduced plasma adiponectin in NASH: Central obesity as an underestimated causative risk factor
Uwe J. F. Tietge, Hartmut H.‐J. Schmidt, Tatjana Schütz, Patrizia Dippe, Herbert Lochs, Matthias Pirlich – 19 January 2005
The liver has a body—A Cook's tour
Adrian Reuben – 19 January 2005
Benefit of TIPS for patients with refractory or recidivant ascites: Serum bilirubin may make the difference
Alexander L. Gerbes, Veit Gülberg – 23 December 2004
HCV persistence: Cure is still a four letter word
Jordan J. Feld, T. Jake Liang – 23 December 2004
Dietary fiber decreases ammonia levels in patients with cirrhosis
Motoh Iwasa, Makoto Nakao, Yoshiaki Kato, Yoshinao Kobayashi, Kenji Takagi, Masahiko Kaito, Yukihiko Adaci – 23 December 2004
Nosocomial transmission of HCV in the liver unit of a tertiary care center
Xavier Forns, Eva Martínez‐Bauer, Anna Feliu, Montserrat García‐Retortillo, Marta Martín, Eugeni Gay, Miquel Navasa, Jose María Sánchez‐Tapias, Miquel Bruguera, Juan Rodés – 23 December 2004 – Despite its medical and legal implications, there are no prospective studies analyzing the incidence and mechanisms involved in the nosocomial transmission of hepatitis C virus (HCV) in liver units. This study prospectively investigates the nosocomial transmission of HCV in the liver unit of a tertiary care center from August 2000 to October 2002.